President
Current• Boutique firm with expertise in drug discovery, translational science, clinical biomarkers, personalized medicine, and clinical development• Engage with private and public investment firms to advise on new technologies and therapeutics• Partner with biotechnology and pharmaceutical companies to review scientific data, clinical development plans, target to disease linkage, and regulatory documents for small and large molecule programs